This inventor holds 16 USPTO granted patents and 12 published patent applications and 4 EPO patents, primarily in Biologics Production. Top assignees: Modernatx, Inc., Moderna Therapeutics, Inc., Archemix Corporation. Active years: 2010-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
9 out of 247 
4 out of 34 
3 out of 24 Years Active: 2010-2020
Areas of Expertise:
Title: The Innovative Mind of Paul Hatala: Contributions to Biologics and mRNA Technology
Introduction: Paul Hatala, an accomplished inventor based in Charlestown, MA, has made significant strides in the field of biotechnology, particularly with his work on modified polynucleotides and lipid nanoparticles. With a remarkable portfolio of 16 patents, Hatala's inventions showcase his commitment to advancing pharmaceutical compositions and therapeutic methods.
Latest Patents: Among Paul Hatala's most notable recent patents are innovations focused on the production of biologics and proteins associated with human diseases. One such invention discusses a pharmaceutical composition comprising lipid nanoparticles that have a mean particle size ranging between 80 nm and 160 nm. These nanoparticles contain mRNA encoding a specific polypeptide, utilizing a combination of cationic and neutral lipids, cholesterol, and PEG lipid. The mRNA included in this composition features a 5'-cap, 5'-UTR, a 3'-UTR, and a poly-A region that consists of at least 100 nucleotides. Another significant patent relates to compositions and methodologies for the preparation, manufacture, and therapeutic application of polynucleotides, primary transcripts, and mmRNA molecules. These innovations pave the way for future breakthroughs in pharmaceutical applications.
Career Highlights: Over the years, Paul Hatala has earned valuable experience with leading biotechnology companies, including ModernaTx, Inc. and Moderna Therapeutics, Inc. His work in these organizations has allowed him to contribute actively to cutting-edge research and development efforts, particularly in the realm of mRNA technology, which has become increasingly pertinent in recent years.
Collaborations: Throughout his career, Paul Hatala has had the opportunity to collaborate with renowned professionals in the field, including Stephane Bancel and Atanu Roy. These partnerships have fostered a synergistic approach to innovation, driving advancements in research that potentially revolutionize treatment methodologies.
Conclusion: Paul Hatala's dedication to innovation and his substantial contributions to the field of biotechnology highlight his pivotal role as an inventor. With a wealth of patented technologies addressing important health issues, Hatala continues to be a transformative figure in the development of novel pharmaceutical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile